Speech is an important indicator of motor function and movement coordination and can be extremely sensitive to involvement in the course of neurologic diseases. The aim of this project is to discover for the first time using simple speech recording and high end pattern analysis preclinical stages of disabling central nervous system disorders including Parkinson's disease and other alpha-synucleinopathies in "at high risk" patients with REM sleep behavior disorder and thus provide one essential prerequisite for trials on REM sleep behavior disorder with preventive therapy.
Seven centers of excellence in sleep research will investigate speech and other clinical symptoms in more than 100 subjects with REM sleep behavior disorder. Analyses of a number of unique speech dimensions based upon three fundamental categories of simple speaking tasks will be used to search for specific prodromal alterations in speech patterns in REM sleep behavior disorder, compared to age- and gender-matched patients with early Parkinson's disease and healthy control subjects. Robust algorithms allowing automated speech analysis will be developed and optimized through English, German, French, Czech and Italian languages. Early motor dysfunction strongly predicts Parkinson's disease and other alpha-synucleinopathies. In this regard, vocal assessment has intriguing potential advances as is non-invasive, inexpensive, simple to administer and scalable to large population with possibility to perform recordings remotely, even by telephone from patients' home. Speech analysis may serve as a simple tool to screen large populations for the risk to develop Parkinson's disease. If speech impairment appears to be a strong biomarker of early motor dysfunction, the screening of speech changes may improve stratification for future neuroprotective therapies for Parkinson's disease and other synucleinopathies.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
350
Each subject will undergo short non-invasive speech assessment lasting approximately 15 minutes that will be recorded using microphone.
Volunteers who enroll in the study will undergo various assessments lasting about 2 hours, including neurological examination of both motor and non-motor skills, autonomic testing and cognitive testing.
Mayo Clinic
Rochester, Minnesota, United States
Medical University of Innsbruck
Innsbruck, Austria
McGill University Health Centre
Montreal, Quebec, Canada
General University Hospital
Prague, CZ, Czechia
Gui-de-Chauliac Hospital
Montpellier, France
University of Marburg
Marburg, Hesse, Germany
San Raffaele Hospital
Milan, Italia, Italy
Motor Speech Disorder Examination (MSDE)
Quantitative acoustic assessment of several deviant speech dimensions connected with phonatory, articulatory, and prosodic abnormalities in hypokinetic dysarthria of Parkinson's disease.
Time frame: Within one session (15 minutes)
MDS Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
The most commonly used scale for the clinical evaluation of Parkinson's disease assessing variety of motor and non-motor symptoms.
Time frame: Within one session (30 minutes)
SCOPA-AUT
Scale for assessment of autonomic dysfunction in Parkinson's disease.
Time frame: Within one session (30 minutes)
Montreal Cognitive Assessment (MoCA)
Scale for assessment of several cognitive domains.
Time frame: Within one session (15 minutes)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.